Next Article in Journal
Previous Article in Journal
Previous Article in Special Issue
Article Menu

Export Article

Open AccessReview
Diseases 2018, 6(3), 63; https://doi.org/10.3390/diseases6030063

秒速赛车开奖官网网址:Inclisiran: A New Promising Agent in the Management of Hypercholesterolemia

1
Department of Medicine, Division of Cardiology, Mount Sinai Hospital, New York, NY 11357, USA
2
Department of Medicine, Mount Sinai St. Luke’s-West Hospital, New York, NY 10025, USA
3
School of Medicine, University of Crete, 71003 Heraklion, Greece
4
Cardiology Clinic, Cardiology Unlimited, PC, New York, NY 10033, USA
5
Department of Medicine, Division of Cardiology, Montefiore Medical Center, Bronx, NY 10467, USA
*
Author to whom correspondence should be addressed.
Academic Editor: Ahmed Bakillah
Received: 29 June 2018 / Revised: 11 July 2018 / Accepted: 11 July 2018 / Published: 13 July 2018

Abstract

The discovery of proprotein convertase subtilisin-kexin type 9 (PCSK9), a serine protease which binds to the low-density lipoprotein (LDL) receptors and targets the receptors for lysosomal degradation, offered an additional route through which plasma LDL-cholesterol (LDL-C) levels can be controlled. Initially, the therapeutic approaches to reduce circulating levels of PCSK9 were focused on the use of monoclonal antibodies. To that effect, evolocumab and alirocumab, two human monoclonal antibodies directed against PCSK9, given on a background of statin therapy, have been shown to markedly decrease LDL-C levels and significantly reduce cardiovascular risk. The small interfering RNA (siRNA) molecules have been used recently to target the hepatic production of PCSK9. siRNA interferes with the expression of specific genes with complementary nucleotide sequences by affecting the degradation of mRNA post-transcription, thus preventing translation. Inclisiran is a long-acting, synthetic siRNA directed against PCSK9 and it has been shown to significantly decrease hepatic production of PCSK9 and cause a marked reduction in LDL-C levels. This review aims to present and discuss the current clinical and scientific evidence pertaining to inclisiran, which is a new promising agent in the management of hypercholesterolemia. View Full-Text
Keywords: proprotein convertase subtilisin-kexin type 9 (PCSK9); small interfering RNA (siRNA); inclisiran; low-density lipoprotein-cholesterol (LDL-C); cardiovascular disease (CVD); cardiovascular risk proprotein convertase subtilisin-kexin type 9 (PCSK9); small interfering RNA (siRNA); inclisiran; low-density lipoprotein-cholesterol (LDL-C); cardiovascular disease (CVD); cardiovascular risk
Figures

秒速赛车是哪里的开奖 www.0dv0k.cn Figure 1

Figure 1
<p>Mechanism of action of inclisiran in conjunction with the action of PCSK9.</p> ">
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Kosmas, C.E.; Mu?oz Estrella, A.; Sourlas, A.; Silverio, D.; Hilario, E.; Montan, P.D.; Guzman, E. Inclisiran: A New Promising Agent in the Management of Hypercholesterolemia. Diseases 2018, 6, 63.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Diseases EISSN 2079-9721 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
秒速赛车是哪里的开奖
Back to Top
  • 天生三条腿 半岁牛犊活成“牛坚强” 2019-02-20
  • 晋中市直机关将开展纪念建党97周年“红色+”系列活动 2019-02-20
  • 吴燕生任中国航天科技集团有限公司董事长 2019-02-20
  • 美国一大学将接受中国高考成绩 美媒:中国学子多了一条路 2019-02-19
  • 台媒曝吴建豪离婚 百亿身家娇妻收两封离婚协议书 2019-02-19
  • 娄勤俭确保江苏"四好农村路"建设走在全国前列 2019-02-18
  • 传媒每周热闻第360期:全国党报网站总编辑贺新春 央视春晚主持阵容曝光 2019-02-18
  • 13少年被逼参与盗窃遭烟头烫伤 21天撬130辆车 2019-02-18
  • 反思“天价账单”要看共性问题 2019-02-18
  • 西部网(陕西新闻网)www.cnwest.com 2019-02-17
  • 权健边路尖刀加盟初期曾被质疑 如今获球迷点赞 2019-02-17
  • 脱下警服当支书 老高回村以后(新时代·面孔) 2019-02-17
  • 党员干部注意了!这些事情不能做 2019-02-16
  • 甘肃裕河:“美猴王”下山 2019-02-16
  • China Fokus Richtungsweisende Zwei Tagungen stellen Weichen für neue ra“ 2019-02-15
  • 780| 146| 499| 648| 692| 186| 810| 671| 700| 426|